Terms: = Colorectal cancer AND TPM3, ENSG00000143549, 7170
30 results:
1. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
Wu S; Liu Y; Shi X; Zhou W; Zeng X
Dig Liver Dis; 2023 Dec; 55(12):1757-1764. PubMed ID: 37142453
[TBL] [Abstract] [Full Text] [Related]
2. Incidence and risk factors of cardiovascular mortality in patients with gastrointestinal adenocarcinoma.
Nso N; Nyabera A; Nassar M; Mbome Y; Emmanuel K; Alshamam M; Sumbly V; Guzman L; Shaukat T; Bhangal R; Ojong GA; Radparvar F; Rizzo V; Munira MS
PLoS One; 2023; 18(1):e0262013. PubMed ID: 36706093
[TBL] [Abstract] [Full Text] [Related]
3. Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas.
Zhang Z; Pang J; Chen L; Chen J; Li J; Liu H; Wang J; Wu H; Liang Z
Hum Pathol; 2022 Nov; 129():21-31. PubMed ID: 35977594
[TBL] [Abstract] [Full Text] [Related]
4. Gene fusions and oncogenic mutations in MLH1 deficient and BRAFV600E wild-type colorectal cancers.
Ukkola I; Nummela P; Kero M; Tammio H; Tuominen J; Kairisto V; Kallajoki M; Haglund C; Peltomäki P; Kytölä S; Ristimäki A
Virchows Arch; 2022 Apr; 480(4):807-817. PubMed ID: 35237889
[TBL] [Abstract] [Full Text] [Related]
5. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
[TBL] [Abstract] [Full Text] [Related]
6. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
[TBL] [Abstract] [Full Text] [Related]
7. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract] [Full Text] [Related]
8. NTRK fusion in Japanese colorectal adenocarcinomas.
Yamashiro Y; Kurihara T; Hayashi T; Suehara Y; Yao T; Kato S; Saito T
Sci Rep; 2021 Mar; 11(1):5635. PubMed ID: 33707574
[TBL] [Abstract] [Full Text] [Related]
9. Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation.
Yan W; Zhang L; Lv F; Moccia M; Carlomagno F; Landry C; Santoro M; Gosselet F; Frett B; Li HY
Eur J Med Chem; 2021 Apr; 216():113265. PubMed ID: 33652352
[TBL] [Abstract] [Full Text] [Related]
10. NTRK fusion-positive colorectal cancer in Japanese population.
Yonemaru J; Hashimoto T; Takayanagi D; Naka T; Yatabe Y; Kanemitsu Y; Shiraishi K; Sekine S
Pathol Int; 2021 May; 71(5):355-359. PubMed ID: 33631044
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer.
Li W; Jin X; Guo S; Xu F; Su X; Jiang X; Wang G
Aging (Albany NY); 2021 Feb; 13(4):5506-5524. PubMed ID: 33536348
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of multiparametric MRI-based radiomics model: Potential role for chemotherapeutic benefits in locally advanced rectal cancer.
Cui Y; Yang W; Ren J; Li D; Du X; Zhang J; Yang X
Radiother Oncol; 2021 Jan; 154():161-169. PubMed ID: 32976874
[TBL] [Abstract] [Full Text] [Related]
13. Pharmacokinetic-Pharmacodynamic-Efficacy Modeling of ONO-7579, a Novel Pan-Tropomyosin Receptor Kinase Inhibitor, in a Murine Xenograft Tumor Model.
Iida H; Fujikawa R; Kozaki R; Harada R; Hosokawa Y; Ogawara KI; Ohno T
J Pharmacol Exp Ther; 2020 Jun; 373(3):361-369. PubMed ID: 32217770
[TBL] [Abstract] [Full Text] [Related]
14. Risk factor analysis for inaccurate pre-operative MRI staging in rectal cancer.
Cai Z; Xie X; Chen Y; Chen Z; Cao W; Saad KSS; Zou Y; Lan P; Wu X
BMC Cancer; 2020 Mar; 20(1):253. PubMed ID: 32216771
[TBL] [Abstract] [Full Text] [Related]
15. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of colorectal cancer.
Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
[TBL] [Abstract] [Full Text] [Related]
16. Epidemiology of and prognostic factors for appendiceal carcinomas: a retrospective, population-based study.
Mo S; Zhou Z; Ying Z; Dai W; Xiang W; Han L; Li Q; Wang R; Cai G
Int J Colorectal Dis; 2019 Nov; 34(11):1915-1924. PubMed ID: 31642969
[TBL] [Abstract] [Full Text] [Related]
17. Colonic Adenocarcinomas Harboring NTRK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature.
Lasota J; Chłopek M; Lamoureux J; Christiansen J; Kowalik A; Wasąg B; Felisiak-Gołąbek A; Agaimy A; Biernat W; Canzonieri V; Centonze G; Chmielik E; Daum O; Dubová M; Dziuba I; Goertz S; Góźdź S; Guttmejer-Nasierowska A; Haglund C; Hałoń A; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kaczorowski M; Kita P; Kołos M; Kopczyński J; Michal M; Milione M; Okoń K; Pęksa R; Pyzlak M; Ristimäki A; Ryś J; Szostak B; Szpor J; Szumiło J; Teresiński L; Waloszczyk P; Wejman J; Wesołowski W; Miettinen M
Am J Surg Pathol; 2020 Feb; 44(2):162-173. PubMed ID: 31567189
[TBL] [Abstract] [Full Text] [Related]
18. In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs.
Kita K; Arai S; Nishiyama A; Taniguchi H; Fukuda K; Wang R; Yamada T; Takeuchi S; Tange S; Tajima A; Nakada M; Yasumoto K; Motoo Y; Murakami T; Yano S
Cancer Med; 2017 Dec; 6(12):2972-2983. PubMed ID: 29125233
[TBL] [Abstract] [Full Text] [Related]
19. Association between serious psychological distress and nonparticipation in cancer screening and the modifying effect of socioeconomic status: Analysis of anonymized data from a national cross-sectional survey in Japan.
Fujiwara M; Inagaki M; Nakaya N; Fujimori M; Higuchi Y; Kakeda K; Uchitomi Y; Yamada N
Cancer; 2018 Feb; 124(3):555-562. PubMed ID: 29076156
[TBL] [Abstract] [Full Text] [Related]
20. Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged cancers.
Fuse MJ; Okada K; Oh-Hara T; Ogura H; Fujita N; Katayama R
Mol Cancer Ther; 2017 Oct; 16(10):2130-2143. PubMed ID: 28751539
[No Abstract] [Full Text] [Related]
[Next]
